Improved Glycaemia Correlates with Liver Fat Reduction in Obese, Type 2 Diabetes, Patients Given Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists

Glucagon-like peptide-1 receptor agonists (GLP-1 RA) are effective for obese patients with type 2 diabetes mellitus (T2DM) because they concomitantly target obesity and dysglycaemia. Considering the high prevalence of non-alcoholic fatty liver disease (NAFLD) in patients with T2DM, we determined the...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Cuthbertson, Daniel J., Irwin, Andrew, Gardner, Chris J., Daousi, Christina, Purewal, Tej, Furlong, Niall, Goenka, Niru, Thomas, E. Louise, Adams, Valerie L., Pushpakom, Sudeep P., Pirmohamed, Munir, Kemp, Graham J.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Public Library of Science 2012
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3516516/
https://ncbi.nlm.nih.gov/pubmed/23236362
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0050117
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak